Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

012023-09

UPDATE ON RESTORATION OF PUBLIC FLOAT
272023-08

ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
152023-08

NOTICE OF BOARD MEETING
012023-08

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
042023-07

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
142023-06

GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH RULE 8.08(1)(A) OF THE LISTING RULES
092023-06

UPDATE ON THE STATUS OF PUBLIC FLOAT AND APPLICATION FOR EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH THE MINIMUM PUBLIC FLOAT REQUIREMENT
052023-06

(Updated) FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022
022023-06

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
012023-06

ARTICLES OF ASSOCIATION
012023-06

(Updated) FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022
012023-06

List of directors and their roles and functions

4 5 6 7 8

The Enterprise OA